{"name":"Engelhard Arzneimittel GmbH & Co.KG","slug":"engelhard-arzneimittel-gmbh-co-kg","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"Cineol","genericName":"Cineole","slug":"cineole","indication":"Other","status":"marketed"},{"name":"Drug containing the active ingredient","genericName":"Drug containing the active ingredient","slug":"drug-containing-the-active-ingredient","indication":"Other","status":"phase_2"},{"name":"Nasal Decongestant","genericName":"Nasal Decongestant","slug":"nasal-decongestant","indication":"Nasal congestion due to colds, allergies, or sinusitis","status":"marketed"}]},{"name":"Respiratory","slug":"respiratory","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Ivy Leaves Cough Liquid","genericName":"Ivy Leaves Cough Liquid","slug":"ivy-leaves-cough-liquid","indication":"Cough associated with respiratory tract conditions","status":"marketed"}]}],"pipeline":[{"name":"Cineol","genericName":"Cineole","slug":"cineole","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Drug containing the active ingredient","genericName":"Drug containing the active ingredient","slug":"drug-containing-the-active-ingredient","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Ivy Leaves Cough Liquid","genericName":"Ivy Leaves Cough Liquid","slug":"ivy-leaves-cough-liquid","phase":"marketed","mechanism":"Ivy leaves extract promotes mucus clearance and reduces airway inflammation to relieve cough symptoms.","indications":["Cough associated with respiratory tract conditions","Productive cough relief"],"catalyst":""},{"name":"Nasal Decongestant","genericName":"Nasal Decongestant","slug":"nasal-decongestant","phase":"marketed","mechanism":"Nasal decongestants work by constricting blood vessels in the nasal mucosa to reduce swelling and improve airflow.","indications":["Nasal congestion due to colds, allergies, or sinusitis"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-03-19","type":"pipeline","source":"boerse.de","summary":"EQS-News: Secarna Pharmaceuticals establishes Advisory Board with financial markets expert Jens Holstein and shareholder representative Richard Mark Engelhard - boerse.de - boerse.de","headline":"EQS-News: Secarna Pharmaceuticals establishes Advisory Board with financial markets expert Jens Holstein and shareholder","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"marketed":3,"phase_2":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}